Skip to content

Detajmium

Drug profile

Also known as: detajmium bitartrate, detajmium bitartrate hydrate, tachmalcor

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Detajmium is a drug catalogued in DrugCentral. Recorded indications include Supraventricular arrhythmia and Ventricular arrhythmia.

  • Indications: Supraventricular arrhythmia and Ventricular arrhythmia.
  • Molecular formula: C27H42N3O3; molecular weight 456.65 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Supraventricular arrhythmia
  • Ventricular arrhythmia

Chemical structure

Molecular formulaC27H42N3O3
Molecular weight456.65 g/mol
CAS number47719-70-0
InChIKeyIXLGLCQSNUMEGQ-PYJPINIGSA-N
PubChem CID118984402
CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)C5=C(C=CC=C5)[C@]44C[C@@H]([C@H]2[C@H]4O)[N@@+]3(CC(O)CN(CC)CC)[C@@H]1O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Detajmium used for?

DrugCentral lists the following indications for Detajmium: Supraventricular arrhythmia and Ventricular arrhythmia.

What is the chemical formula of Detajmium?

Detajmium has the molecular formula C27H42N3O3 and a molecular weight of 456.65 g/mol.

Browse: all drugs starting with D · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications2
FormulaC27H42N3O3
DrugCentral ID823
Interactive profile